What Researchers Did
Doctors described two patients who developed bone damage in the jaw linked to bisphosphonate drugs, one in the upper jaw and one in the lower jaw, and outlined ideas for preventing and managing this problem.
What They Found
This is a two-case report describing bisphosphonate-related osteonecrosis of the jaws, one case in the maxilla and one in the mandible, managed with long-term antibiotics and minimal surgical debridement rather than major ablative surgery. The abstract does not report whether these treatments resolved the condition, how long treatment lasted, or any outcome measures for either patient. The authors also summarize general clinical recommendations on prevention and management drawn from existing published literature, not from these two cases specifically.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a report of only two cases with no comparison group, no statistical analysis, and no reported outcome data, so the treatment approach and recommendations cannot be generalized to other patients.